5/9/2013

Shire announced plans to use Nimbus' discovery platform to develop an oral drug for lysosomal storage disorders. Nimbus will use its drug discovery software to screen molecules that could attack the disease, then Shire will conduct clinical trials and commercialize the product.

Full Story:
Xconomy

Related Summaries